Skip to main content
TA

terenz.ai

Terenz has developed a medical image analysis platform that employs deep learning algorithms to detect and monitor diseases such as Parkinson's disease and papillary thyroid cancer from MRI and digital pathology scans. This technology enables healthcare professionals to identify abnormalities more accurately and expedite diagnoses, ultimately improving patient outcomes.

Busan, South KoreaFounded 202011100+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

The early and accurate detection of diseases like Parkinson's and papillary thyroid cancer often relies on subjective interpretation of medical images, leading to potential delays and inconsistencies in diagnosis. Traditional diagnostic methods may lack the sensitivity needed to identify subtle indicators of disease progression, impacting timely intervention and patient outcomes.

Solution

Terenz offers an AI-powered medical image analysis platform designed to enhance the precision and efficiency of disease detection and monitoring. The platform utilizes deep learning algorithms to analyze MRI and digital pathology scans, identifying subtle anomalies indicative of diseases such as Parkinson's and papillary thyroid cancer. By automating and augmenting the image review process, Terenz aims to provide healthcare professionals with objective, data-driven insights, facilitating earlier and more accurate diagnoses. The platform's AI solutions can assist in predicting disease progression and monitoring treatment response, enabling clinicians to make informed decisions and personalize patient care.

Target Audience

The primary target audience includes healthcare professionals, radiologists, pathologists, and hospitals seeking to improve diagnostic accuracy and efficiency in detecting and monitoring diseases through advanced medical image analysis.

Features

  • AI-driven analysis of MRI and digital pathology scans for Parkinson's disease and papillary thyroid cancer
  • 3D convolutional neural networks for detecting Parkinson's disease from 3T T1 weighted MRI scans
  • AI-based analysis of digital cell pathology for papillary thyroid cancer
  • Algorithms for early detection of Alzheimer’s Disease from 1.5 T MRI Scans
  • Tools for predicting disease progression and monitoring treatment response
  • Integration with existing hospital systems and workflows
This profile is AI-generated and may contain inaccuracies.